Select Medical Holdings Corporation (the “Company” or “Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) has announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, Martin F. Jackson, Senior Executive Vice President of Strategic Finance and Operations of Select Medical, and Welsh, Carson, Anderson & Stowe (“WCAS” and, together with Mr. Ortenzio and Mr. Jackson, the “Consortium”) pursuant to the terms of the Agreement and Plan of Merger, dated as of March 2, 2026 (the “Merger Agreement”). The previously announced purchase price of $16.50 per share represents a premium of approximately 18% over Select Medical’s unaffected share price as of November 24, 2025.
Read the full article: Select Medical Holdings Corporation Acquired by Consortium Led by Robert A. Ortenzio, Martin F. Jackson, and WCAS //
Source: https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-acquired-by-consortium-led-by-robert-a-ortenzio-martin-f-jackson-and-wcas-302814693.html